Skip to content

Neuroscientific Biopharmaceuticals says EmtinB shows promise as a multiple sclerosis treatment

By Gold Cross - September 1, 2021

Multiple sclerosis
This article is only available to ITK members and is restricted for Pharmacists. Please or Register as a Pharmacist to read the content.
Share this article:
Source Stockhead
Article tags

Articles you might be interested in

, ,

First Aus-NZ clinical guidance developed for people living with multiple sclerosis

Gold Cross | February 10, 2025
, ,

All in the eyes: High resolution retinal maps aid disease diagnoses

Gold Cross | February 5, 2025
Pharmacist Only
,

Medical professionals fear cases of B6 toxicity are under-reported

Gold Cross | January 28, 2025
,

What’s the difference between a food allergy and an intolerance?

Gold Cross | January 28, 2025
BD Rowa automation gives you back 6 hours in your day

Latest Posts

Pharmacist Only
Unstoppable and spared from impacts of Ex-Tropical Cyclone Alfred: APP2025 to go ahead as planned
Gold Cross | March 10, 2025
New STI impacts 1 in 3 women: landmark study reveals men are the missing link
Gold Cross | March 10, 2025
Pharmacist Only
Two weeks until APP2025 brings the pharmacy industry together on the Gold Coast
Gold Cross | March 6, 2025

Featured Posts

GOLD CROSS endorses Team Medical®
Gold Cross | February 18, 2025
College training supports new Australian Government women’s health initiative
Gold Cross | February 10, 2025
Professor Anna Peeters appointed VicHealth CEO
Gold Cross | February 4, 2025

Tags

Scroll To Top